Improving HIV medication adherence using a smartphone app and health coaching
mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV
This study is testing whether a smartphone app and health coaching can help people with HIV remember to take their medication better than just health coaching alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rhode Island Hospital Academic / other |
| Locations | 2 sites (Atlanta, Georgia and 1 other locations) |
| Trial ID | NCT05046392 on ClinicalTrials.gov |
What this trial studies
This study tests an innovative intervention aimed at improving medication adherence among individuals living with HIV. Participants will receive a health coaching session along with access to a smartphone application that provides medication reminders and allows for remote communication with their health coach. The study will enroll 400 participants across two sites, with a focus on comparing the effectiveness of the app-enhanced intervention against a standard health coaching session. Data will be collected through interviews at multiple time points to assess adherence to antiretroviral therapy (ART) and other related factors.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are diagnosed with HIV, prescribed ART, and have a detectable viral load with less than 100% self-reported medication adherence.
Not a fit: Patients with cognitive impairments, active psychosis, or those who are not fluent in English may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance medication adherence among people living with HIV, leading to better health outcomes and reduced transmission rates.
How similar studies have performed: Previous studies have shown promise in using mobile health interventions to improve medication adherence, indicating that this approach has potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * at least 18 years of age * prescribed ART * diagnosed with HIV * detectable viral load (\>20 copies/mL) in past 6 months * less than 100% self-reported medication adherence Exclusion Criteria: * physical impairments that would prevent completion of the intervention * cognitive impairments that jeopardize informed consent and/or intervention comprehension * active psychosis * not fluent in English
Where this trial is running
Atlanta, Georgia and 1 other locations
- Emory University — Atlanta, Georgia, United States (Not_yet_recruiting)
- Rhode Island Hospital — Providence, Rhode Island, United States (Recruiting)
Study contacts
- Study coordinator: Susan Ramsey, PhD
- Email: sramsey@lifespan.org
- Phone: (401) 444-7831
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.